Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3 Publisher Pubmed



Nazari F¹ ; Sinaei F¹ ; Nilipour Y² ; Petit F³ ; Oveisgharan S¹ ; Nassiritoosi M⁴ ; Razzaghyazar M⁵ ; Mahmoudi M⁶ ; Nafissi S^{1, 7} Show Affiliations
Source: Journal of Clinical Neuromuscular Disease Published:2018

Abstract

Objectives: Glycogen storage disease type 3 (GSD-III) is a rare inherited metabolic disorder caused by glycogen debranching enzyme deficiency. Various pathogenic mutations of the AGL gene lead to abnormal accumulation of glycogen in liver, skeletal, and cardiac muscles. Here, we report distinct clinical and genetic data of Iranian patients with GSD-III. Methods: Clinical and laboratory data of 5 patients with GSDIII were recorded. Genetic investigation was performed to identify the causative mutations. Results: Three patients had typical liver involvement in childhood and one was diagnosed 2 years after liver transplantation for cirrhosis of unknown etiology. Four patients had vacuolar myopathy with glycogen excess in muscle biopsy. All patients had novel homozygous mutations of the AGL gene namely c.378T>A, c.3295T>C, c.3777G>A, c.2002-2A>G, and c.1183C>T. Conclusions: This is the first comprehensive report of patients with GSD-III in Iran with 2 uncommon clinical presentations and 5 novel mutations in the AGL gene. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.